Yusuke Sato

发表

Integrated molecular analysis of clear-cell renal cell carcinoma

H. Aburatani, H. Kume, Y. Homma, 2013, Nature Genetics.

Dynamics of clonal evolution in myelodysplastic syndromes

S. Miyano, T. LaFramboise, Y. Shiraishi, 2016, Nature Genetics.

Frequent pathway mutations of splicing machinery in myelodysplasia

S. Sugano, Yutaka Suzuki, S. Miyano, 2011, Nature.

An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data

H. Kume, Y. Homma, S. Miyano, 2013, Nucleic acids research.

The genomic landscape of nasopharyngeal carcinoma

S. Ogawa, B. Goh, P. MacAry, 2014, Nature Genetics.

Genomic and molecular characterization of esophageal squamous cell carcinoma

Li Shang, Xin Xu, Henry Yang, 2014, Nature Genetics.

Genome-Wide Analysis of Ocular Adnexal Lymphoproliferative Disorders Using High-Resolution Single Nucleotide Polymorphism Array.

S. Ogawa, Yusuke Sato, A. Sato-Otsubo, 2015, Investigative ophthalmology & visual science.

Two patients with 19p13.2 deletion (Malan syndrome) involving NFIX and CACNA1A with overgrowth, developmental delay, and epilepsy

S. Ogawa, Yusuke Sato, Y. Kuroda, 2017, Clinical dysmorphology.

Classification of clear cell renal cell carcinoma based on PKM alternative splicing

J. Nielsen, J. Borén, M. Uhlén, 2019, bioRxiv.

Classification of clear cell renal cell carcinoma based on PKM alternative splicing

J. Nielsen, J. Borén, M. Uhlén, 2019, bioRxiv.

Epigenetic regulation of REG1A and chemosensitivity of cutaneous melanoma

Yusuke Sato, M. Sim, D. Hoon, 2013, Epigenetics.

Title Aberrant splicing and defective mRNA production induced bysomatic spliceosome mutations in myelodysplasia

M. Cazzola, S. Miyano, Y. Shiraishi, 2019 .

Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia

M. Cazzola, S. Miyano, Y. Shiraishi, 2018, Nature Communications.

S. Tsunoda, S. Miyano, K. Mimori, 2019, Nature.

Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma

Satoru Miyano, Yuichi Shiraishi, Teppei Shimamura, 2015, Nature Communications.

Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms

Masao Nagasaki, Satoru Miyano, Yuichi Shiraishi, 2012, Nature Genetics.

Mutational landscape and clonal architecture in grade II and III gliomas

Satoru Miyano, Yuichi Shiraishi, Toshihiko Wakabayashi, 2015, Nature Genetics.

Identification of the genetic and clinical characteristics of neuroblastomas using genome-wide analysis

S. Miyano, Y. Shiraishi, K. Chiba, 2017, Oncotarget.

Gene expression and risk of leukemic transformation in myelodysplasia.

Satoru Miyano, Yuichi Shiraishi, Kenichi Chiba, 2017, Blood.

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment

Yusuke Sato, D. Hoon, Y. Goto, 2009, Cancer Microenvironment.

Discovery of Functional Alternatively Spliced PKM Transcripts in Human Cancers

H. Kume, J. Borén, Björn Forsström, 2019, bioRxiv.

Integrated Molecular Characterization of the Lethal Pediatric Cancer Pancreatoblastoma.

S. Miyano, T. Shimamura, Y. Shiraishi, 2018, Cancer research.

Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma Biallelic DICER1 mutations in sporadic PPB

S. Miyano, T. Shimamura, Y. Shiraishi, 2014 .

Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy

S. Ogawa, H. Tsukahara, Motohiro Kato, 2016, Journal of Human Genetics.

Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy

H. Kume, T. Tsunoda, S. Ogawa, 2020, Nature Communications.

Different Mutant Splicing Factors Cause Distinct Missplicing Events and Give Rise to Different Clinical Phenotypes in Myelodysplastic Syndromes

M. Cazzola, S. Miyano, Y. Shiraishi, 2015 .

Comprehensive Analysis of Aberrant RNA Splicing in Myelodysplastic Syndromes

M. Cazzola, S. Miyano, Y. Shiraishi, 2014 .

In Analogy to AML, MDS Can be Sub-Classified By Ancestral Mutations

S. Miyano, T. LaFramboise, Y. Shiraishi, 2014 .

Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays

S. Ogawa, Y. Hayashi, Motohiro Kato, 2014, Cancer science.

Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism

H. Aburatani, S. Miyano, Hiromichi Suzuki, 2022, Oncogene.

Recurrent Mutations of Multiple Components of Cohesin Complex in Myeloid Neoplasms

S. Ishikawa, H. Aburatani, K. Shirahige, 2012 .

Integrated molecular analysis of adult T cell leukemia/lymphoma

H. Aburatani, O. Nureki, T. Kawaguchi, 2015, Nature Genetics.

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach

H. Kume, J. Borén, M. Uhlén, 2022, EBioMedicine.

Somatic RHOA mutation in angioimmunoblastic T cell lymphoma

O. Nureki, S. Miyano, Y. Shiraishi, 2014, Nature Genetics.

BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA‐like breast cancers treated with neoadjuvant chemotherapy

S. Ogawa, M. Kurosumi, Yusuke Sato, 2017, Genes, chromosomes & cancer.

Molecular classification and diagnostics of upper urinary tract urothelial carcinoma.

H. Aburatani, A. Lenis, H. Kume, 2021, Cancer cell.

Genomic landscape of liposarcoma

Christoph, O. Myklebost, S. Miyano, 2015, Oncotarget.

Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer

D. Absher, D. Rakheja, S. Ogawa, 2018, Clinical Cancer Research.

Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma

H. Kume, Y. Homma, S. Ogawa, 2016, Cancer Immunology Research.

Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma.

S. Miyano, T. Shimamura, Y. Shiraishi, 2014, Cancer research.

Recurrent somatic mutations underlie corticotropin-independent Cushing’s syndrome

O. Nureki, H. Kume, Y. Homma, 2014, Science.

Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer

J. Brooks, H. Kume, Y. Homma, 2017, Oncotarget.

S. Tsunoda, S. Miyano, K. Mimori, 2019, Nature.

Truncation and microdeletion of EVC/EVC2 with missense mutation of EFCAB7 in Ellis‐van Creveld syndrome

Seishi Ogawa, S. Ogawa, M. Mizuguchi, 2016, Congenital anomalies.

Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study

H. Putter, A. Giuliano, D. Elashoff, 2012, Breast Cancer Research and Treatment.

Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets

S. Miyano, T. Shimamura, Y. Shiraishi, 2020, npj Precision Oncology.

Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

S. Miyano, B. Dumitriu, Y. Shiraishi, 2015, The New England journal of medicine.

Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma.

O. Nureki, S. Miyano, T. Shibata, 2015, Blood.

The landscape of somatic mutations in Down syndrome–related myeloid disorders

S. Miyano, Y. Shiraishi, K. Chiba, 2013, Nature Genetics.

Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.

S. Miyano, Y. Shiraishi, K. Chiba, 2017, Blood.

Impact of genetic alterations in stem-cell transplantation for myelodysplasia and secondary acute myeloid leukemia Short title: Genetic alterations in myelodysplasia with HCT

S. Miyano, Y. Shiraishi, K. Chiba, 2017 .

Genomic analysis of clonal origin of Langerhans cell histiocytosis following acute lymphoblastic leukaemia

S. Miyano, Y. Shiraishi, K. Chiba, 2016, British journal of haematology.

Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.

S. Ogawa, Yusuke Sato, A. Sato-Otsubo, 2011, Blood.

De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome.

N. Kenmochi, S. Miyano, Y. Shiraishi, 2018, American journal of human genetics.

HapMuC: somatic mutation calling using heterozygous germ line variants near candidate mutations

Yusuke Sato, Satoru Miyano, Yuichi Shiraishi, 2014, Bioinform..

Biallelic DICER 1 mutations in sporadic PPB 2 Financial support

S. Miyano, T. Shimamura, Y. Shiraishi, 2014 .

Molecular and Cellular Pathobiology Biallelic DICER 1 Mutations in Sporadic Pleuropulmonary Blastoma

S. Miyano, T. Shimamura, Y. Shiraishi, 2014 .

Revised version 2 ) Biallelic DICER 1 mutations in sporadic pleuropulmonary blastoma Running title Biallelic DICER 1 mutations in sporadic PPB

S. Miyano, T. Shimamura, Y. Shiraishi, 2014 .

Variegated RHOA mutations in adult T-cell leukemia/lymphoma.

O. Nureki, S. Miyano, Y. Totoki, 2016, Blood.

Abstract 3294: Clonal evolution and integral analysis of hepatoblastoma

S. Miyano, S. Ogawa, Y. Hayashi, 2015 .

Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning

J. Nielsen, H. Kume, J. Borén, 2021, iScience.

Frequent Activating Somatic Alterations in T-Cell Receptor / NF-κb Signaling in Adult T-Cell Leukemia/Lymphoma

S. Miyano, Y. Totoki, T. Shibata, 2015 .

A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation

S. Ogawa, B. Fairfax, Yusuke Sato, 2023, BMC Cancer.

Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children

S. Miyano, Y. Shiraishi, K. Chiba, 2017, Leukemia.

mutations in adult T-cell leukemia / lymphoma

O. Nureki, S. Miyano, Y. Totoki, 2015 .

Landscape of Genetic Alterations in Adult T-Cell Leukemia/Lymphoma

H. Aburatani, O. Nureki, S. Miyano, 2014 .

Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinoma.

H. Kume, T. Kohno, Y. Shiraishi, 2023, Cell reports.

Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma

H. Aburatani, S. Miyano, T. Shimamura, 2015, Nature Communications.

Genomic landscape of liposarcoma

O. Myklebost, Y. Shiraishi, K. Chiba, 2015, OncoTarget.

Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma

H. Aburatani, S. Miyano, Y. Shiraishi, 2015, Nature Communications.

Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.

S. Ogawa, Yusuke Sato, A. Sato-Otsubo, 2011, Blood.

TCEB1-mutated Renal Cell Carcinoma: A Distinct Genomic and Morphologic Subtype

C. Sander, H. Kume, Y. Homma, 2014, Modern Pathology.

Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

S. Miyano, B. Dumitriu, Y. Shiraishi, 2015, The New England journal of medicine.